C20H16F7NO2
Neat
435.34
Room Temperature
380499-07-0; (2R)-2-[(1R)-1-[3, 5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-5, 6-dihydro-2H-1, 4-oxazine; Aprimin; Aprepitant metabolite M-2; 38EA8GN2BN; (6R)-6-[(1R)-1-[3, 5-bis(trifluoromethyl)phenyl]ethoxy]-5-(4-fluorophenyl)-3, 6-dihydro-2H-1, 4-oxazine; UNII-38EA8GN2BN; (2R)-2-((1R)-1-(3, 5-Bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)-5, 6-dihydro-2H-1, 4-oxazine; 2H-1, 4-Oxazine, 2-((1R)-1-(3, 5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)-5, 6-dihydro-, (2R)-; 934540-48-4; KHOSCFXAHZBOCH-ADLMAVQZSA-N; Aprepitant Impurity 22; Aprepitant Impurity 69; SCHEMBL264537; DTXSID30437709; AG-F-33940; DB-289751; (2R)-2-[(1R)-1-[3, 5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-5, 6-dihydro-2H-1, 4-oxazine;; (R)-6-((R)-1-(3, 5-bis(trifluoromethyl)phenyl)ethoxy)-5-(4-fluorophenyl)-3, 6-dihydro-2H-1, 4-oxazine; 2H-1, 4-Oxazine, 2-[(1R)-1-[3, 5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-5, 6-dihydro- and (2R)-rel-
(6R)-6-[(1R)-1-[3, 5-bis(trifluoromethyl)phenyl]ethoxy]-5-(4-fluorophenyl)-3, 6-dihydro-2H-1 and 4-oxazine
InChI=1S/C20H16F7NO2/c1-11(13-8-14(19(22,23)24)10-15(9-13)20(25,26)27)30-18-17(28-6-7-29-18)12-2-4-16(21)5-3-12/h2-5,8-11,18H,6-7H2,1H3/t11-,18-/m1/s1